NCT00880308View on ClinicalTrials.gov

Dose Finding and Safety of Oral LDE225 in Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Advanced Solid Tumor CancersMedulloblastomaBasal Cell Carcinoma
Interventions
DRUG

LDE225

Trial Locations (5)

8091

Novartis Investigative Site, Zurich

15213

University of Pittsburgh Medical Center SC, Pittsburgh

78229

Cancer Therapy & Research Center / UT Health Science Center InstituteForDrugDevelopment(5), San Antonio

08035

Novartis Investigative Site, Barcelona

LE1 5WW

Novartis Investigative Site, Leicester

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY